DEA Strips 2 CVS Pharmacies Of Drug Licenses

Law360, New York (September 12, 2012, 12:11 PM EDT) -- The U.S. Drug Enforcement Administration has revoked the controlled substances licenses of two CVS Caremark Corp. pharmacies accused of filling suspicious orders for painkiller oxycodone as part of a crackdown on prescription drug abuse, ahead of a D.C. Circuit hearing Wednesday over earlier agency decisions to just suspend the pharmacies’ licenses.

In its motion asking to seal a letter listing its specific reasons for the license revocations — filed just a day before the appeals court heard oral argument in the case — the DEA said...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.